Substitution approved for Orencia (abatacept) shortages
Published
Loading...
To help manage the shortage of the Orencia (abatacept) 125 mg single dose syringe and the 125 mg ClickJect autoinjector for subcutaneous injection, we have made a Serious Scarcity Substitution Instrument - external site (SSSI). The SSSI starts on 15 May 2024 and allows a pharmacist to substitute one product for the other if appropriate, without a new prescription from the prescriber.